{"disease":{"id":"alcohol-withdrawal-syndrome","name":"Alcohol withdrawal syndrome","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":4,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"diazepam","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Valium","generic_name":"diazepam","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Adenosine receptor A3, Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2","drug_class":"Benzodiazepine [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"chlordiazepoxide","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chlordiazepoxide Hydrochloride","generic_name":"CHLORDIAZEPOXIDE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Benzodiazepine","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"clorazepate","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tranxene","generic_name":"clorazepate","company_name":"Ajenat Pharms","drug_phase":"marketed","molecular_target":"GABA-A receptor alpha-1/beta-2/gamma-2","drug_class":"Benzodiazepine","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"clomethiazole","indication_name":"Alcohol withdrawal syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Emineurina","generic_name":"CLOMETHIAZOLE","company_name":"","drug_phase":"discontinued","molecular_target":"GABA-A receptor alpha-1/beta-3/gamma-2","drug_class":"clomethiazole","quality_score":0,"revenue":null,"mechanism":"Emineurina works by enhancing the activity of the neurotransmitter GABA, which helps to calm excessive brain activity."}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04973202","title":"Portrayal of Hospital Alcohol Detoxification in France","phase":"","overall_status":"COMPLETED","enrollment_count":50000,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT06555679","title":"Evaluation of a Predictive Score for the Onset of Moderate to Severe Alcohol Withdrawal Syndrome, the PAWSS, in a Population of Intensive Care Patients at Brest University Hospital","phase":"","overall_status":"COMPLETED","enrollment_count":403,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT03235531","title":"Assessment of Valproate on Ethanol Withdrawal","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":210,"lead_sponsor_name":"CAMC Health System","has_results":false},{"nct_id":"NCT06589973","title":"Effect of Clinical and Biochemical Variables Over Morbidity and Mortality in Alcohol Withdrawal Syndrome Patients","phase":"","overall_status":"RECRUITING","enrollment_count":195,"lead_sponsor_name":"Hospital General de Mexico","has_results":false},{"nct_id":"NCT03033823","title":"MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT02052440","title":"Preventing Alcohol Withdrawal Syndrome With Oral Baclofen","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":102,"lead_sponsor_name":"Denver Health and Hospital Authority","has_results":true},{"nct_id":"NCT03012815","title":"Gabapentin for Alcohol Withdrawal Syndrome","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Mayo Clinic","has_results":true},{"nct_id":"NCT03788889","title":"Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketamine","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Santa Barbara Cottage Hospital","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}